The nitric oxide redox sibling nitroxyl partially circumvents impairment of platelet nitric oxide responsiveness

Rustem Dautov, Doan Ngo, G Licari, S Liu, Aaron L Sverdlov, Rebecca H Ritchie, Barbara Kathryn Harper, John David Horowitz, Yuliy Y Chirkov

Research output: Contribution to journalArticleResearchpeer-review

22 Citations (Scopus)

Abstract

Impaired platelet responsiveness to nitric oxide (NO resistance) is a common characteristic of many cardiovascular disease states and represents an independent risk factor for cardiac events and mortality. NO resistance reflects both scavenging of NO by superoxide (O2-), and impairment of the NO receptor, soluble guanylate cyclase (sGC). There is thus an urgent need for circumvention of NO resistance in order to improve clinical outcomes. Nitroxyl (HNO), like NO, produces vasodilator and anti-aggregatory effects, largely via sGC activation, but is not inactivated by O2-. We tested the hypothesis that HNO circumvents NO resistance in human platelets. In 57 subjects with or without ischemic heart disease, platelet responses to the HNO donor isopropylamine NONOate (IPA/NO) and the NO donor sodium nitroprusside (SNP) were compared. While SNP (10muM) induced 29+/-3 (p
Original languageEnglish
Pages (from-to)72 - 78
Number of pages7
JournalNitric Oxide-Biology and Chemistry
Volume35
DOIs
Publication statusPublished - 2013

Cite this